Woman Dies Immediately After Getting COVID-19 Vaccine in Virginia

by TVR Staff

Published February 21, 2021 | Vaccination, Risk & Failure Reports

A 58-year-old mother, grandmother and minister died on Jan. 30, 2021 in Tappahannock, Virginia less than an hour after receiving the first dose of Pfizer/BioNTech’s experimental messenger RNA (mRNA) BNT162b2 vaccine for COVID-19. After getting the shot at a clinic in Warsaw, VA, Drene Keyes (left in photo) waited the recommended 15 minutes to make sure she did not suffer any immediate side effects of the vaccine.^{1 2 3 4}

Epinephrine and Oxygen Had No Effect on Sudden Adverse Event Following COVID-19 Shot

Keyes’ daughter, Lisa Jones, said a co-worker recounted that, after leaving the clinic, her mother was “trying to get in the car and said ‘something’s not right.’” Keyes began having trouble breathing and

started vomiting. She returned to the clinic where a doctor administered a shot of epinephrine in one of her legs and a second shot of epinephrine in an arm. Keyes was also given oxygen.^{2 3 4 5}

Jones said:

They tried to remove fluid from her lungs. They called it ‘flash pulmonary edema,’ and doctors told me that it can be caused by anaphylaxis. The doctor told me that often during anaphylaxis, chemicals are released inside of a person’s body and can cause this to happen.⁴

Anaphylaxis is a known side effect of many vaccines,⁶ including mRNA COVID-19 vaccines.^{7 8 9} The U.S. Centers for Disease Control and Prevenntion (CDC) states that, “Anaphylaxis, an acute and potentially life-threatening allergic reaction, has been reported following vaccination with Pfizer/BioNTech and Moderna COVID-19 vaccines.” Symptoms of anaphylaxis include respiratory distress (shortness of breath), vomiting, abdominal pain/cramps, dizziness/fainting, acute change in mental status, hives/itching, swelling of lips, tongue, mouth, face, extremities and more.¹⁰

Virginia Health Commissioner Does Not Believe Sudden Death Was Related to COVID-19 Shot

While an official cause of death has not been determined, Virginia health commissioner Norman Oliver, MD said he did not believe Keyes died of an allergic reaction to the vaccine. “Preliminary findings indicate that the cause of death was not anaphylaxis,” Dr. Oliver said.³

Dr. Oliver added:

We can confirm that the death occurred within hours of having received the vaccine, but that is not evidence of it being related. We are currently investigating and do not yet know the cause of death.³

Danny Avula, MD, who is director of the Richmond City and Henrico County health departments and Virginia’s vaccine coordinator, said, “They’re looking for patterns, they’re looking for a causation versus just a correlation based on time.”⁵

According to a news report, the sudden death of Drene Keyes has been reported to the Vaccine Adverse Event Reporting System (VAERS) by the Virginia Department of Health (VDH).² The U.S Food and Drug Administration (FDA) states that, “VAERS accepts reports of adverse events that may be associated with U.S. licensed vaccines from health care providers, manufacturers, and the public.”¹¹

Jointly operated by the FDA and CDC, VAERS was created by Congress under the National Childhood Vaccine Injury Act of 1986 in response to growing public concern about the safety of whole cell pertussis vaccine in DPT (diphtheria-pertussis-tetanus) and other childhood vaccines.¹²

VA Chief Medical Examiner Declines to Conduct Autopsy After COVID-19 Vaccine Related Death Citing “Public Health Concerns”

As of last week, the cause of Keyes’ death had not been determined. A news report noted that the Office of the Chief Medical Examiner of Virginia had informed Jones that it had no plans to perform an autopsy on her mother. Jones reportedly said she was told that the state would not do a full autopsy “due to public health concerns.”^{1 5 13}

According to her Jones, her mother had underlying health conditions, including diabetes and obesity, high cholesterol and high blood pressure.s.⁵ Jones told one reporter that she feels more tests should have been performed before her mother’s body was released, adding “I think there is a lot we don’t know on how the vaccine works in people with underlying health conditions.”¹³

Before the FDA granted Pfizer an EUA to distribute its experimental mRNA COVID-19 vaccine, Phase 2/3 clinical trials enrolling about 43,000 participants were conducted by the company, of which about half received the experimental vaccine and half received a placebo.¹⁴ Most trial subjects were healthy and between the ages of 18 and 55 years old, while more than 80 percent were white and less than 10 percent were black. About eight percent of the participants in Phase 2/3 clinical trials had diabetes and half of them received the vaccine.¹⁵

---

Click here to view References:

  anaphylaxis, BioNTech, BNT162b2, CDC, Centers for Disease Control and Prevention, COVID-19, Danny Avula, diphtheria-pertussis-tetanus, DPT, Drene Keyes, FDA, Food and Drug Administration, Lisa Jones, Marco Cáceres, mRNA vaccines, National Childhood Vaccine Injury Act of 1986, National Vaccine Information Center, Norman Oliver, NVIC, Pfizer, Tappahannock, The Vaccine Reaction, Vaccine Adverse Event Reporting System, VAERS, Virginia